Pathways to treatments for better sleep in people living with MS

Dr Laura Laslett

MENZIES INSTIUTE FOR MEDICAL RESEARCH, UNIVERSITY OF TASMANIA, TAS

January 2024

specialisation: Social And Applied Research

focus area: Better treatments

funding type: Fellowship

project type: Investigator Led Research

Summary

Dr Laura Laslett’s research aims to investigate sleep in people living with MS. She will do this by collecting better information on sleep, understanding what treatments have already been tested for sleep, how sleep changes over time, and whether magnetic brain stimulation improves sleep, all in people living with MS.

To do this, she will use research grade fitness tracking watches to assess sleep continuously for 14 days, an app (MySymptoms) to report MS symptoms (including sleep) each day and will investigate whether this information adds value to information gathered using standard questionnaires on sleep.

Dr Laslett will review and summarise clinical trials already completed on sleep in people living with MS, to find out what treatments have been tested and to identify the most promising treatments for poor sleep.

To assess changes in sleep in Australians living with MS, Dr Laslett will assess how various aspects of sleep change over time, including changes in sleep quality, daytime sleepiness, and symptoms of restless legs syndrome over four years, using data from the Australian MS Longitudinal Study (AMSLS). She will also assess which factors are associated with any change in sleep quality over four years.

To investigate whether magnetic brain stimulation improves sleep, Dr Laslett will use data from the MagneTic brAin stimUlation foR mUltiple Sclerosis (TAURUS.2) trial, which is a clinical trial of magnetic brain stimulation in people living with MS. She will assess whether there is a relationship between the number and size of lesions seen on MRI scans and quality of sleep. She will also determine whether magnetic brain stimulation (daily for four weeks) is effective in improving sleep quality over four months.

Using this information, Dr Laslett will plan future clinical trials of treatments for poor sleep in people living with MS.

Progress

Dr Laslett and her team reviewed research studies that assessed sleep over time in people living with MS, including those that assessed sleep using activity monitors. They found 10 studies assessed sleep using activity monitors over time, most of which were randomised controlled trials. These trials used behavioural interventions (physical activity, mindfulness, cognitive behaviour therapy (CBT)), medications (eszopiclone and melatonin), and transcranial direct current stimulation (tDCS). The studies usually measured sleep using activity monitors for only seven days and typically measured factors that could be assessed by questionnaire, such as total time spent asleep. Few studies used the range of data that activity monitors can capture and few measured sleep factors that questionnaires are unable to assess accurately, such as the number of awakenings overnight. There is no clear picture yet whether activity monitors capture better outcomes for assessing the effectiveness of interventions than questionnaires. 

From reviewing the literature for the “Modifiable lifestyle factors for MS” report (2025 update), Dr Laslett and her team learned that CBT, physical activity and multidisciplinary interventions (combining CBT, physical activity and sleep hygiene) are effective, evidence-based modifiable lifestyle therapies for some sleep difficulties in plwMS. These findings could greatly improve sleep and quality of life in plwMS by providing evidence-based guidance to plwMS and their clinicians. 

Dr Laslett has published her findings in three papers in peer reviewed journals. She currently has three more publications under review and is preparing another three manuscripts for publication. Over the next year, Dr Laslett and her team will collect and analyse sleep data from plwMS. She will finish identifying promising sleep interventions from completed trials and will start co-designing an intervention to deliver sleep education to plwMS. Dr Laslett and her team will also continue analysing changes in sleep over time using AMSLS data and analyse data from TAURUS.2 to determine whether magnetic brain stimulation improves sleep. 

publications

  • Dagnew B, Laslett LL, Honan CA, Blizzard L, Winzenberg T, Taylor BV, van der Mei I (2024). The association of comorbidities with sleep quality among Australians with multiple sclerosis: Insights from the Australian Multiple Sclerosis Longitudinal Study. Mult Scler 30:877-887. 
  • Stevens N, Ezegbe C, Fuh-Ngwa V, Makowiecki K, Zarghami A, Nguyen PT, Sansom J, Smith K, Laslett LL, Denham M, Cullen CL, Barnett MH, Hinder MR, Breslin M, Young KM, Taylor BV (2024). A phase II trial examining the safety and preliminary efficacy of repetitive transcranial magnetic stimulation (rTMS) for people living with multiple sclerosis. Trials 25:598. 
  • Dagnew B, Honan CA, Laslett LL, Taylor BV, Campbell J, Blizzard L, van der Mei I (2025). Impact of sleep quality on health-related quality of life domains and the mediating effects of symptoms in people with multiple sclerosis. Qual Life Res 34:563-575. 

Last updated 31 March 2025

lead investigator

co-investigator

Professor Ingrid van der Mei
Professor Bruce Taylor

total funding

$225,000

start year

2024

duration

3 years

STATUS

Current project

Stages of the research process

Fundamental laboratory Research

Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.

Lab to clinic timeline

10+ years

Translational Research

Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.

Lab to clinic timeline

5+ years

Clinical Studies and Clinical Trials

Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.

Lab to clinic timeline

3+ years

Read More

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Pathways to treatments for better sleep in people living with MS